Status:
COMPLETED
Tajik Migrant Health Education Study
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Prisma Research Center
Conditions:
HIV Infections
Hepatitis C
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This study will test the efficacy of a peer-education prevention intervention to reduce risky drug, alcohol, and sexual behaviors among male Tajik labor migrants who inject drugs (MWID) while working ...
Detailed Description
The investigators will recruit male Tajik migrants who inject drugs from 12 different sites in Moscow, including bazaars and other work sites. In both study arms, the recruited men (index participants...
Eligibility Criteria
Inclusion
- adult Tajik man
- injected drugs in past 30 days
- living and working as migrant laborer in Moscow
Exclusion
- does not intend to stay in Moscow for the next 12 months
Key Trial Info
Start Date :
October 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 28 2023
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT04853394
Start Date
October 19 2021
End Date
May 28 2023
Last Update
December 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PRISMA Research Center
Moscow, Russia